Wu Adela, Ugiliweneza Beatrice, Wang Dengzhi, Hsin Gary, Boakye Maxwell, Skirboll Stephen
Department of Neurosurgery, Stanford University, Palo Alto, California, USA.
Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Neurooncol Pract. 2022 Mar 30;9(4):299-309. doi: 10.1093/nop/npac026. eCollection 2022 Aug.
Glioblastoma (GBM) carries a poor prognosis despite standard of care. Early palliative care (PC) has been shown to enhance survival and quality of life while reducing healthcare costs for other cancers. This study investigates differences in PC timing on outcomes for patients with GBM.
This study used Surveillance, Epidemiology, and End Results (SEER)-Medicare data from 1997 to 2016. Based on ICD codes, three groups were defined: (1) early PC within 10 weeks of diagnosis, (2) late PC, and (3) no PC. Outcomes were compared between the three groups.
Out of 10 812 patients with GBM, 1648 (15.24%) patients had PC consultation with an overall positive trend over time. There were no significant differences in patient characteristics. The late PC group had significantly higher number of hospice claims (1.06 ± 0.69) compared to those without PC, in the last month of life. There were significant differences in survival among the three groups ( < .0001), with late PC patients with the longest mean time to death from diagnosis (11.72 ± 13.20 months).
We present the first investigation of PC consultation prevalence and outcomes, stratified by early versus late timing, for adult GBM patients. Despite an overall increase in PC consultations, only a minority of GBM patients receive PC. Patients with late PC had the longest survival times and had greater hospice use in the last month of life compared to other subgroups. Prospective studies can provide additional valuable information about this unique population of patients with GBM.
尽管有标准治疗方案,但胶质母细胞瘤(GBM)的预后仍然很差。早期姑息治疗(PC)已被证明可以提高生存率和生活质量,同时降低其他癌症的医疗成本。本研究调查了GBM患者接受PC的时机差异对治疗结果的影响。
本研究使用了1997年至2016年的监测、流行病学和最终结果(SEER)-医疗保险数据。根据国际疾病分类代码,定义了三组:(1)诊断后10周内接受早期PC,(2)晚期PC,(3)未接受PC。比较了三组之间的治疗结果。
在10812例GBM患者中,1648例(15.24%)患者接受了PC咨询,且总体呈随时间上升趋势。患者特征方面无显著差异。晚期PC组在生命的最后一个月的临终关怀索赔次数(1.06±0.69)显著高于未接受PC的组。三组之间的生存率存在显著差异(P<0.0001),晚期PC患者从诊断到死亡的平均时间最长(11.72±13.20个月)。
我们首次对成年GBM患者按早期与晚期分层的PC咨询患病率和治疗结果进行了调查。尽管PC咨询总体有所增加,但只有少数GBM患者接受了PC。与其他亚组相比,晚期PC患者的生存时间最长,且在生命的最后一个月使用临终关怀的比例更高。前瞻性研究可以为这一独特的GBM患者群体提供更多有价值的信息。